Monday , June 14 2021

Zydus Cadila completes Phase 1 trails for its antimalaria compound

In addition, a malaria challenge trial involving the P. falciparum volunteer infection study
(VIS) model was also conducted in Australia to determine the safety and tolerability and to
characterize the antimalarial activity of a single-dose oral administration of ZY-19489 in
healthy adult volunteers [Reg’n Number ACTRN12619001215112]. No serious or severe
drug-related adverse events were observed.In addition, a malaria challenge trial involving the P. falciparum volunteer infection study
(VIS) model was also conducted in Australia to determine the safety and tolerability and to
characterize the antimalarial activity of a single-dose oral administration of ZY-19489 in
healthy adult volunteers [Reg’n Number ACTRN12619001215112]. No serious or severe
drug-related adverse events were observed.Read More

About

Check Also

Reasons to invest in a Bajaj Finance Online Fixed Deposit

Pune (Maharashtra) [India], June 14 (ANI/NewsVoir): A fixed deposit is one of the most solid …

Leave a Reply

Your email address will not be published. Required fields are marked *